FDA Approves Cancer Immuotherapy drug Keytruda

Options

The FDA has approved the Cancer Immunotherapy drug Keytruda for Melanoma.

Keytruda is a PD 1 checkpoint inhibitor and it is thought this type of treatment should eventually

work for all types of solid tumors including BC. Other trials are underway.

Researcher are now involved in combining checkpoint inhibitors with CART and TIL T Cell immunotherapy.

Drs are calling this a game changer.

http://www.usatoday.com/story/money/business/2014/...

http://www.nytimes.com/2014/09/05/business/merck-w...

http://www.washingtonpost.com/national/health-science/fda-approves-new-kind-of-cancer-drug-keytruda-for-treating-melanoma/2014/09/04/65f6a1c6-3476-11e4-a723-fa3895a25d02_story.html

Comments

Categories